Organization
Medicine and Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States of America
1 abstract
Abstract
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP CLINICAL TRIAL OF NIPOCALIMAB IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (SPIREA): STUDY DESIGNOrg: Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, United States of America, Medicine and Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States of America, Janssen Medical Affairs Global Services, LLC, Buenos Aires, Argentina, Janssen Research & Development, LLC, Spring House, PA, United States of America, Janssen Pharmaceutica, Vilvoorde, Belgium,